- Home
- SGU vs FTRE Comparison
SGU vs FTRE Comparison
Compare SGU & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGU
- FTRE
- Stock Information
- Founded
- SGU 1995
- FTRE 1996
- Country
- SGU United States
- FTRE United States
- Employees
- SGU N/A
- FTRE N/A
- Industry
- SGU Other Specialty Stores
- FTRE Medical Specialities
- Sector
- SGU Consumer Discretionary
- FTRE Health Care
- Exchange
- SGU Nasdaq
- FTRE Nasdaq
- Market Cap
- SGU 445.9M
- FTRE 469.0M
- IPO Year
- SGU 1995
- FTRE N/A
- Fundamental
- Price
- SGU $11.71
- FTRE $5.32
- Analyst Decision
- SGU
- FTRE Hold
- Analyst Count
- SGU 0
- FTRE 11
- Target Price
- SGU N/A
- FTRE $17.10
- AVG Volume (30 Days)
- SGU 37.8K
- FTRE 2.7M
- Earning Date
- SGU 07-30-2025
- FTRE 08-11-2025
- Dividend Yield
- SGU 6.30%
- FTRE N/A
- EPS Growth
- SGU 123.45
- FTRE N/A
- EPS
- SGU 1.78
- FTRE N/A
- Revenue
- SGU $1,803,079,000.00
- FTRE $2,685,600,000.00
- Revenue This Year
- SGU N/A
- FTRE N/A
- Revenue Next Year
- SGU N/A
- FTRE $1.36
- P/E Ratio
- SGU $6.62
- FTRE N/A
- Revenue Growth
- SGU 2.38
- FTRE N/A
- 52 Week Low
- SGU $10.11
- FTRE $3.97
- 52 Week High
- SGU $13.75
- FTRE $28.41
- Technical
- Relative Strength Index (RSI)
- SGU 40.56
- FTRE 49.95
- Support Level
- SGU $11.93
- FTRE $3.97
- Resistance Level
- SGU $11.95
- FTRE $6.56
- Average True Range (ATR)
- SGU 0.28
- FTRE 0.49
- MACD
- SGU -0.00
- FTRE 0.10
- Stochastic Oscillator
- SGU 24.42
- FTRE 52.12
About SGU Star Group L.P.
Star Group LP is a company engaged in providing home heating products and services to residential and commercial customers. The company offers heating oil and air conditioning equipment, as well as home security and plumbing services. The company also sells diesel fuel, gasoline, and home heating oil. Geographically, the company operates in U.S.
About FTRE Fortrea Holdings Inc.
Fortrea Holdings is a late-stage contract research organization, or CRO, that provides comprehensive Phase I through IV clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.